載入...
Developments in Post-marketing Comparative Effectiveness Research
Physicians and insurers need to weigh the effectiveness of new drugs against existing therapeutics in routine care to make decisions about treatment and formularies. Because Food and Drug Administration (FDA) approval of most new drugs requires demonstrating efficacy and safety against placebo, ther...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2905665/ https://ncbi.nlm.nih.gov/pubmed/17554243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.clpt.6100249 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|